首页 > 最新文献

International Journal of Life Science and Pharma Research最新文献

英文 中文
Concept of Kshara and Its Sources in Ayurveda- A Critical Review 阿育吠陀中Kshara的概念及其来源——一个批判性的回顾
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l72-l85
Shreya Soni, Sheetal Asutkar, Sandeep Kumar Upadhyay, Amar Pundlik Kadav
Kshara’ is related to ‘Paka’ (preparation) and ‘vidhi’ (application). Because of its superiority among the sharper andauxiliary instruments, caustic alkali performs excision, incision, and scarification, alleviating three doshas and being used forspecific functions. Among the para-surgical measures, all three- Agni (cauterization), Kshara (caustic alkali), and Jalauka (leeches)are important. Still, kshara is the chief because operations excision, incision, etc., cannot be performed by Agni and Jalauka. It isalso applied for specific purposes, such as in Arsha caused by Pitta. This article will be essential in containing from the smallest todeepest knowledge of Akshara, which is available in classics & articles in scattered forms. This study intends to gather allinformation related to Kshara and elaborate on their properties as mentioned in classics, especially in Sushruta Samhita andRasashashtra. The method followed here thoroughly analyzes Sushruta Samhita, its commentaries, and various research articlesthat surfed online. It is found that Sushruta Samhita explains full information regarding Kshara, types, indications, andcontraindications.In contrast, certain dravya, which are not explained as Kshara but possess Kshara properties, are also discussed.The research provides thorough literature & critical review of Kshara, its sources, and their properties which can benefit manydiseases in terms of application in different forms. In this study, the aim is to gather information about Kshara mentioned inclassics and articles. This study aims to collect information about Kshara from traditional and scholarly sources.
Kshara与Paka(准备)和vidhi(应用)有关。由于它在利器和辅助器具中具有优越性,烧碱具有切除、切开、划伤的作用,减轻了三刀,具有特定的功能。在手术旁的措施中,所有三种——Agni(烧灼),Kshara(烧碱)和Jalauka(水蛭)都是重要的。尽管如此,kshara仍然是主要的,因为手术切除,切口等,不能由Agni和Jalauka进行。它也适用于特定目的,例如在由皮塔引起的Arsha。这篇文章将是必不可少的,包含从最小到最深的知识的阿克沙拉,这是可在经典& &;散乱的物品。本研究旨在收集所有与Kshara有关的信息,并详细阐述经典中提到的Kshara的属性,特别是在Sushruta Samhita和rasashashtra中。本文所采用的方法彻底分析了Sushruta Samhita、它的评论和网上浏览的各种研究文章。我们发现,《苏舒鲁塔》解释了有关Kshara、类型、适应症和禁忌症的全部信息。与此相反,也讨论了某些不被解释为Kshara但具有Kshara属性的dravya。本研究提供了详尽的文献资料。对Kshara、其来源及其在不同形式的应用方面对许多疾病有益的特性进行批判性审查。在本研究中,目的是收集有关Kshara提到的经典和文章的信息。本研究旨在从传统和学术来源中收集关于迦罗的信息。
{"title":"Concept of Kshara and Its Sources in Ayurveda- A Critical Review","authors":"Shreya Soni, Sheetal Asutkar, Sandeep Kumar Upadhyay, Amar Pundlik Kadav","doi":"10.22376/ijlpr.2023.13.6.l72-l85","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l72-l85","url":null,"abstract":"Kshara’ is related to ‘Paka’ (preparation) and ‘vidhi’ (application). Because of its superiority among the sharper andauxiliary instruments, caustic alkali performs excision, incision, and scarification, alleviating three doshas and being used forspecific functions. Among the para-surgical measures, all three- Agni (cauterization), Kshara (caustic alkali), and Jalauka (leeches)are important. Still, kshara is the chief because operations excision, incision, etc., cannot be performed by Agni and Jalauka. It isalso applied for specific purposes, such as in Arsha caused by Pitta. This article will be essential in containing from the smallest todeepest knowledge of Akshara, which is available in classics & articles in scattered forms. This study intends to gather allinformation related to Kshara and elaborate on their properties as mentioned in classics, especially in Sushruta Samhita andRasashashtra. The method followed here thoroughly analyzes Sushruta Samhita, its commentaries, and various research articlesthat surfed online. It is found that Sushruta Samhita explains full information regarding Kshara, types, indications, andcontraindications.In contrast, certain dravya, which are not explained as Kshara but possess Kshara properties, are also discussed.The research provides thorough literature & critical review of Kshara, its sources, and their properties which can benefit manydiseases in terms of application in different forms. In this study, the aim is to gather information about Kshara mentioned inclassics and articles. This study aims to collect information about Kshara from traditional and scholarly sources.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"309 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134902851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological and Non-Pharmacological Management of Obstructive Sleep Apnea 阻塞性睡眠呼吸暂停的药物和非药物治疗
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l531-l542
Jahnavi Purna Gorripati, Surekha Dubey Godbole
Obstructive sleep apnea (O.S.A.), also referred to as obstructive sleep hypopnea – is a sleep disorder that involvescessation or significant decrease in airflow in the presence of breathing effort. It is the most common type of sleep-disorderedbreathing. It is characterized by episodes of total or partial airway collapse and decreased oxygen saturation or sleep arousal. Asa result of this disturbance, sleep is interrupted and non-restorative. It significantly raises morbidity and mortality in both developedand developing countries. This review aims to review relevant studies on obstructive sleep apnea. The method used is acomputerized search method, the pathophysiology, clinical presentation, complications, diagnostic procedures, and therapeuticchoices from the literature. The effects of O.S.A. on cardiovascular health, mental disease, quality of life, and driving safety aresevere. This course of action highlights the interprofessional team's involvement in treating obstructive sleep apnea, itspathophysiology, and its causes.
阻塞性睡眠呼吸暂停(O.S.A.),也被称为阻塞性睡眠低通气,是一种睡眠障碍,涉及呼吸困难时气流停止或明显减少。这是最常见的睡眠呼吸障碍。其特征是发作性的全部或部分气道塌陷,血氧饱和度降低或睡眠觉醒。由于这种干扰,睡眠被打断,无法恢复。它大大提高了发达国家和发展中国家的发病率和死亡率。本文就阻塞性睡眠呼吸暂停的相关研究进行综述。使用的方法是计算机搜索方法,病理生理学,临床表现,并发症,诊断程序和治疗选择从文献。osa对心血管健康、精神疾病、生活质量和驾驶安全的影响是严重的。这一行动方案突出了跨专业团队在治疗阻塞性睡眠呼吸暂停、其病理生理学及其原因方面的参与。
{"title":"Pharmacological and Non-Pharmacological Management of Obstructive Sleep Apnea","authors":"Jahnavi Purna Gorripati, Surekha Dubey Godbole","doi":"10.22376/ijlpr.2023.13.6.l531-l542","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l531-l542","url":null,"abstract":"Obstructive sleep apnea (O.S.A.), also referred to as obstructive sleep hypopnea – is a sleep disorder that involvescessation or significant decrease in airflow in the presence of breathing effort. It is the most common type of sleep-disorderedbreathing. It is characterized by episodes of total or partial airway collapse and decreased oxygen saturation or sleep arousal. Asa result of this disturbance, sleep is interrupted and non-restorative. It significantly raises morbidity and mortality in both developedand developing countries. This review aims to review relevant studies on obstructive sleep apnea. The method used is acomputerized search method, the pathophysiology, clinical presentation, complications, diagnostic procedures, and therapeuticchoices from the literature. The effects of O.S.A. on cardiovascular health, mental disease, quality of life, and driving safety aresevere. This course of action highlights the interprofessional team's involvement in treating obstructive sleep apnea, itspathophysiology, and its causes.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"230 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135371899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital Subtraction Radiography in Dentistry: An Overview 数字减影放射照相在牙科:概述
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l368-l374
Dr. Prasanna R. Sonar, Dr. Aarati S. Panchbhai
Digital imaging has transformed the field of medical and dental imaging by overcoming many of the drawbacks ofconventional film-based radiographs. These alterations, however, are hidden behind a background of typical anatomical featuresand are not readily visible, making it difficult for the human eye to discern them. One image-enhancing method or tool that solvesthis issue is digital subtraction radiography, which has recently found usage in a number of dental specialties. Quantitative measuresfrom digital subtraction pictures have been validated as a result of the development of digital imaging technology. Moreover,changes made to computer software have made the clinical use of subtraction imaging more adaptable. Digital subtraction radiologyhas significantly improved the ability to find oral and maxillofacial lesions. Comparing standardised radiographs acquired duringsuccessive examination sessions is done using digital subtraction radiography. Any structures that have not changed are removed,and these regions are shown in the subtraction picture as neutral grey areas, whilst parts that have altered are shown as deeperor brighter shades of grey. Yet, there is not much analysis of this often used method in the literature. The purpose of this articleis to examine this technology, its applications in different areas of dentistry, and its potential for detecting a range of disorders.This review article highlights its basic principles, applications, technique, advantages, disadvantages and future scope of digitalsubtraction radiography in dentistry.
数字成像技术克服了传统胶片射线照相技术的许多缺点,从而改变了医学和牙科成像领域。然而,这些变化隐藏在典型解剖特征的背景后面,不容易看到,因此人眼很难识别它们。解决这个问题的一种图像增强方法或工具是数字减影放射照相,最近在许多牙科专业中得到了应用。随着数字成像技术的发展,数字减法图像的定量测量方法已经得到了验证。此外,计算机软件的改进使减法成像的临床应用更具适应性。数字减影放射学显著提高了发现口腔颌面部病变的能力。比较在连续检查期间获得的标准化x线照片使用数字减影x线摄影完成。任何没有改变的结构都被移除,这些区域在减法图中显示为中性灰色区域,而改变的部分则显示为更深更亮的灰色阴影。然而,文献中对这种常用方法的分析并不多。本文的目的是研究这项技术,它在牙科不同领域的应用,以及它在检测一系列疾病方面的潜力。本文综述了数字减影放射照相的基本原理、应用、技术、优缺点及在牙科中的应用前景。
{"title":"Digital Subtraction Radiography in Dentistry: An Overview","authors":"Dr. Prasanna R. Sonar, Dr. Aarati S. Panchbhai","doi":"10.22376/ijlpr.2023.13.6.l368-l374","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l368-l374","url":null,"abstract":"Digital imaging has transformed the field of medical and dental imaging by overcoming many of the drawbacks ofconventional film-based radiographs. These alterations, however, are hidden behind a background of typical anatomical featuresand are not readily visible, making it difficult for the human eye to discern them. One image-enhancing method or tool that solvesthis issue is digital subtraction radiography, which has recently found usage in a number of dental specialties. Quantitative measuresfrom digital subtraction pictures have been validated as a result of the development of digital imaging technology. Moreover,changes made to computer software have made the clinical use of subtraction imaging more adaptable. Digital subtraction radiologyhas significantly improved the ability to find oral and maxillofacial lesions. Comparing standardised radiographs acquired duringsuccessive examination sessions is done using digital subtraction radiography. Any structures that have not changed are removed,and these regions are shown in the subtraction picture as neutral grey areas, whilst parts that have altered are shown as deeperor brighter shades of grey. Yet, there is not much analysis of this often used method in the literature. The purpose of this articleis to examine this technology, its applications in different areas of dentistry, and its potential for detecting a range of disorders.This review article highlights its basic principles, applications, technique, advantages, disadvantages and future scope of digitalsubtraction radiography in dentistry.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"232 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135372040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Approaches to Enhance Solubility Medicine 提高溶解度药物的新方法
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.p217-p233
Anurag Kumar Yadav, Harsh Kumar Pandey, Aditya Shiven
The solubility enhancement of poorly aqueous soluble drugs presents a significant challenge in pharmaceuticalformulation. Liquisolid technology, also known as powdered solution technology, has emerged as a promising approach toenhance the solubility and bioavailability of such drugs. This paper provides a detailed discussion of the novel approachesemployed within the framework of Liquisolid technology to overcome solubility limitations. The study explores the principles,advantages, and applications of Liquisolid technology in drug formulation, highlighting its potential to revolutionize oralmedication delivery. This research aims to investigate the effectiveness of Liquisolid technology in enhancing drug solubility,elucidate its underlying mechanisms, and evaluate its impact on drug dissolution, bioavailability, and therapeutic outcomes. Theobjectives are to review the background and challenges associated with poor solubility of drugs, introduce the concept ofLiquisolid technology and its principles, discuss the advantages and benefits of Liquisolid technology in solubility enhancement,explore the formulation strategies and key components involved in Liquisolid formulations, evaluate the in vitro and in vivoperformance of Liquisolid systems, and identify future research directions and potential applications of Liquisolid technology inpharmaceutical development. Through this comprehensive analysis, the study aims to provide valuable insights into the novelapproaches based on Liquisolid technology for enhancing drug solubility, facilitating the development of effective and efficientdrug delivery systems. Liquisolid technology, a novel approach to solubility enhancement, offers promising advantages overconventional techniques. It involves solubilizing poorly aqueous soluble drugs using surfactants, then incorporating thesesolubilized drugs into a carrier system or powdered solution. The powdered solution facilitates the conversion of the solubilizeddrug into solid residues, which can be further processed into different dosage forms.
提高难溶性药物的溶解度是目前制剂研究的一个重要课题。液体固体技术,也称为粉末溶液技术,已成为提高这类药物的溶解度和生物利用度的一种有前途的方法。本文详细讨论了在液态固体技术框架内采用的新方法来克服溶解度限制。本研究探讨了液体固体技术在药物配方中的原理、优势和应用,强调了其在口服给药方面的革命性潜力。本研究旨在探讨液体固体技术提高药物溶解度的有效性,阐明其潜在机制,并评估其对药物溶出度、生物利用度和治疗效果的影响。本文综述了药物溶解度差的背景和挑战,介绍了液体固体技术的概念及其原理,讨论了液体固体技术在提高溶解度方面的优势和益处,探讨了液体固体制剂的配方策略和关键成分,评价了液体固体系统的体外和体内性能。确定未来的研究方向和液体固体技术在药物开发中的潜在应用。通过这一综合分析,本研究旨在为基于液体固体技术的新方法提供有价值的见解,以提高药物的溶解度,促进有效和高效药物递送系统的发展。液体固体技术是一种新型的提高溶解度的方法,与传统的技术相比具有很好的优势。它包括使用表面活性剂溶解水溶性差的药物,然后将这些溶解的药物纳入载体系统或粉末状溶液。粉末状溶液有助于将溶解的药物转化为固体残留物,可进一步加工成不同的剂型。
{"title":"Novel Approaches to Enhance Solubility Medicine","authors":"Anurag Kumar Yadav, Harsh Kumar Pandey, Aditya Shiven","doi":"10.22376/ijlpr.2023.13.6.p217-p233","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.p217-p233","url":null,"abstract":"The solubility enhancement of poorly aqueous soluble drugs presents a significant challenge in pharmaceuticalformulation. Liquisolid technology, also known as powdered solution technology, has emerged as a promising approach toenhance the solubility and bioavailability of such drugs. This paper provides a detailed discussion of the novel approachesemployed within the framework of Liquisolid technology to overcome solubility limitations. The study explores the principles,advantages, and applications of Liquisolid technology in drug formulation, highlighting its potential to revolutionize oralmedication delivery. This research aims to investigate the effectiveness of Liquisolid technology in enhancing drug solubility,elucidate its underlying mechanisms, and evaluate its impact on drug dissolution, bioavailability, and therapeutic outcomes. Theobjectives are to review the background and challenges associated with poor solubility of drugs, introduce the concept ofLiquisolid technology and its principles, discuss the advantages and benefits of Liquisolid technology in solubility enhancement,explore the formulation strategies and key components involved in Liquisolid formulations, evaluate the in vitro and in vivoperformance of Liquisolid systems, and identify future research directions and potential applications of Liquisolid technology inpharmaceutical development. Through this comprehensive analysis, the study aims to provide valuable insights into the novelapproaches based on Liquisolid technology for enhancing drug solubility, facilitating the development of effective and efficientdrug delivery systems. Liquisolid technology, a novel approach to solubility enhancement, offers promising advantages overconventional techniques. It involves solubilizing poorly aqueous soluble drugs using surfactants, then incorporating thesesolubilized drugs into a carrier system or powdered solution. The powdered solution facilitates the conversion of the solubilizeddrug into solid residues, which can be further processed into different dosage forms.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"54 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135454969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Katigraha Through Ayurveda – A Case Report 通过阿育吠陀治疗卡提格拉哈- 1例报告
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l86-l91
Swapnil Bhoyar, Dr. Sourabh Deshmukh, Dr. Trupti Thakre, Utkarsha Khaire
The description of Katigraha is not available as a separate entity in the classics. It is described amongst the eighty by Nanatmaja Vatavyadhi in the Charak Samhita. Ayurveda provides a horizon for such patients with its miraculous treatments of Panchakarma, Shamana, Rasayana, Agnikarma, etc. Lumbar canal stenosis is an abnormal narrowing of the spinal canal in the lumbar region, resulting in a neurological deficit that produces symptoms like pain, numbness, paraesthesia, and loss of motor function. Abnormal weight distribution combined with soft tissue laxity and instability over a prolonged period allows for excessive joint play and buckling of the posterior annular fibres of the intervertebral disc (IVD). The main treatment protocol, according to Ayurveda, is the use of both purification and palliative treatment. This case report represents a 56-year-old male patient who came to the OPD complaining of pain in his lumbar, hip, and legs; tingling sensation; stiffness; and walking difficulty. At Kati Pradesh, the trauma caused by the fall led to the vitiation of Vata and kha- vaigunya. Additionally, Agnimandya was already there, which caused ama to develop. He was given both Shodhana and Shamana Chikitsa. There was a significant improvement in the symptoms, and the patient could do his routine work without any support. This case and its results show that this therapy is effective in lumbar canal stenosis and should be done in a large population. Patients with lumbar canal stenosis can be effectively treated with Panchkarma procedures and oral medications without surgical intervention.
在经典中,对Katigraha的描述并不是一个单独的实体。那纳塔玛迦·瓦塔瓦雅迪在《查拉克·沙密塔》中描述了这八十个人。阿育吠陀为这些患者提供了Panchakarma, Shamana, Rasayana, Agnikarma等神奇治疗的视野。腰椎管狭窄是腰椎区域椎管的异常狭窄,导致神经功能障碍,产生疼痛、麻木、感觉异常和运动功能丧失等症状。异常的体重分布加上软组织的松弛和不稳定,会导致过度的关节活动和椎间盘后环纤维的屈曲。根据阿育吠陀的说法,主要的治疗方案是净化和姑息治疗的结合。这个病例报告是一个56岁的男性病人,他来到OPD抱怨他的腰椎、髋关节和腿部疼痛;刺痛的感觉;刚度;还有行走困难。在卡蒂邦,由坠落造成的创伤导致了Vata和kha- vaigunya的破坏。此外,阿格尼曼迪亚已经在那里了,这导致了ama的发展。他得到了Shodhana和Shamana Chikitsa。症状有了明显的改善,病人可以在没有任何支持的情况下做日常工作。该病例及其结果表明,这种治疗方法对腰椎管狭窄症有效,应在大量人群中进行。腰椎管狭窄的患者可以通过Panchkarma手术和口服药物有效治疗,而无需手术干预。
{"title":"Management of Katigraha Through Ayurveda – A Case Report","authors":"Swapnil Bhoyar, Dr. Sourabh Deshmukh, Dr. Trupti Thakre, Utkarsha Khaire","doi":"10.22376/ijlpr.2023.13.6.l86-l91","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l86-l91","url":null,"abstract":"The description of Katigraha is not available as a separate entity in the classics. It is described amongst the eighty by Nanatmaja Vatavyadhi in the Charak Samhita. Ayurveda provides a horizon for such patients with its miraculous treatments of Panchakarma, Shamana, Rasayana, Agnikarma, etc. Lumbar canal stenosis is an abnormal narrowing of the spinal canal in the lumbar region, resulting in a neurological deficit that produces symptoms like pain, numbness, paraesthesia, and loss of motor function. Abnormal weight distribution combined with soft tissue laxity and instability over a prolonged period allows for excessive joint play and buckling of the posterior annular fibres of the intervertebral disc (IVD). The main treatment protocol, according to Ayurveda, is the use of both purification and palliative treatment. This case report represents a 56-year-old male patient who came to the OPD complaining of pain in his lumbar, hip, and legs; tingling sensation; stiffness; and walking difficulty. At Kati Pradesh, the trauma caused by the fall led to the vitiation of Vata and kha- vaigunya. Additionally, Agnimandya was already there, which caused ama to develop. He was given both Shodhana and Shamana Chikitsa. There was a significant improvement in the symptoms, and the patient could do his routine work without any support. This case and its results show that this therapy is effective in lumbar canal stenosis and should be done in a large population. Patients with lumbar canal stenosis can be effectively treated with Panchkarma procedures and oral medications without surgical intervention.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"730 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136372451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Ayurveda in Management of Attention Deficit Hyperactivity Disorder: A Case Report 阿育吠陀在治疗注意缺陷多动障碍中的作用:1例报告
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l293-l299
Dr. Manisha Panda, Dr. Renu B. Rathi, Dr. Jyothy K B, Dr. Srihari S
ADHD is a neurodevelopmental disorder manifested by a constant pattern of inattention and/ or hyperactivityimpulsivity which hinders with functioning and development of brain. Inattention refers to difficulty in focusing due to lack of grasping/ retaining things which are instructed to do. Hyperactivity refers to the constant movements when the situation is not appropriate. Impulsivity means one may act without thinking or having difficulty with self-control, it may also involve inability to delay gratification. Systematic reviews illustrate that globally, community prevalence rate is between 2% and 7% with an average of around 5%. Our aim is to prove the efficacy of Ayurvedic interventions in the management of ADHD. Objectives are to reduce the symptoms of hyperactivity, inattention, and impulsivity significantly according to DSM-V criteria. A male patient aged 7 years was brought by his parents to the Paediatric OPD with complaints of lack of concentration since duration of 4 years, easy irritability, shouting, head banging and inability to speak sentences properly, then by interrogation and physical examination the patient was diagnosed to be suffering from attention deficit hyperactivity disorder with reference to DSM-V criteria. Then he was given Ayurvedic interventions while receiving three sittings of treatment. Results & discussion include significant reduction of symptoms of inattention, hyperactivity and impulsivity under DSM-5 criteria was observed in the patient after three sittings of treatment because of the mode of action of the drugs in the respective formulations and the strengthening therapy of the procedures done during the sittings. Therefore, we conclude this case study establishes the fact that ADHD can be managed by Ayurvedic interventions so that the child can be able to perform his daily activities. This multimodal approach along with occupational therapy works as wonder in the management of attention deficit hyperactivity disorder.
ADHD是一种神经发育障碍,表现为持续的注意力不集中和/或过度活跃和冲动,阻碍了大脑的功能和发育。注意力不集中指的是由于没有抓住或记住指示要做的事情而难以集中注意力。多动是指在不合适的情况下不断地运动。冲动意味着一个人可能不经思考就采取行动,或者在自我控制方面有困难,它也可能涉及无法延迟满足。系统审查表明,全球社区患病率在2%至7%之间,平均约为5%。我们的目的是证明阿育吠陀干预治疗多动症的有效性。目的是根据DSM-V标准显著减少多动、注意力不集中和冲动的症状。一名7岁男性患者由其父母带至儿科门诊,主诉4年来注意力不集中、易烦躁、大喊大叫、撞头、不能正常说话,经询问和体格检查,参照DSM-V标准诊断为注意缺陷多动障碍。然后他在接受三次治疗的同时接受阿育吠陀治疗。结果,讨论包括在DSM-5标准下的注意力不集中、多动和冲动症状的显著减少,这是在三次治疗后观察到的,因为在各自的配方中药物的作用模式以及在治疗期间进行的程序的强化治疗。因此,我们得出结论,这个案例研究建立了一个事实,即多动症可以通过阿育吠陀干预来管理,这样孩子就可以进行他的日常活动。这种多模式方法与职业疗法一起在管理注意缺陷多动障碍方面发挥了神奇的作用。
{"title":"Role of Ayurveda in Management of Attention Deficit Hyperactivity Disorder: A Case Report","authors":"Dr. Manisha Panda, Dr. Renu B. Rathi, Dr. Jyothy K B, Dr. Srihari S","doi":"10.22376/ijlpr.2023.13.6.l293-l299","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l293-l299","url":null,"abstract":"ADHD is a neurodevelopmental disorder manifested by a constant pattern of inattention and/ or hyperactivityimpulsivity which hinders with functioning and development of brain. Inattention refers to difficulty in focusing due to lack of grasping/ retaining things which are instructed to do. Hyperactivity refers to the constant movements when the situation is not appropriate. Impulsivity means one may act without thinking or having difficulty with self-control, it may also involve inability to delay gratification. Systematic reviews illustrate that globally, community prevalence rate is between 2% and 7% with an average of around 5%. Our aim is to prove the efficacy of Ayurvedic interventions in the management of ADHD. Objectives are to reduce the symptoms of hyperactivity, inattention, and impulsivity significantly according to DSM-V criteria. A male patient aged 7 years was brought by his parents to the Paediatric OPD with complaints of lack of concentration since duration of 4 years, easy irritability, shouting, head banging and inability to speak sentences properly, then by interrogation and physical examination the patient was diagnosed to be suffering from attention deficit hyperactivity disorder with reference to DSM-V criteria. Then he was given Ayurvedic interventions while receiving three sittings of treatment. Results & discussion include significant reduction of symptoms of inattention, hyperactivity and impulsivity under DSM-5 criteria was observed in the patient after three sittings of treatment because of the mode of action of the drugs in the respective formulations and the strengthening therapy of the procedures done during the sittings. Therefore, we conclude this case study establishes the fact that ADHD can be managed by Ayurvedic interventions so that the child can be able to perform his daily activities. This multimodal approach along with occupational therapy works as wonder in the management of attention deficit hyperactivity disorder.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"270 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134902852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptual Study of Shatkriyakala and Its Applicability in Surgical Diseases Shatkriyakala的概念研究及其在外科疾病中的应用
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l37-l44
Dr. Akshay Kumar, Dr. Devyani Dasar, Dr. Pariksha Sharma
: In Ayurveda, "shatkriyakal" sanchaya, prakopa, prasara, sthanasanshraya, vyakti, and bheda explains the causes of diseaseprogression, or its etiopathogenesis. These six stages represent the six opportunities for a doctor to treat the condition beforeit becomes severe. It is a composite expression of the words Kriya and Kala. Kriya denotes the choice of therapy (medication,diet, and daily routine) used to treat the Dosha disruption, and Kala denotes the stage of a disease's progression. The idea ofKriyakala has been described by the ancient Indian surgeon Sushruta. Many authors have tried writing and compiling thereferences or information in classical texts. Still, there is no single article that not only compiles the textual references but alsoexplains its appropriate applied aspect or correlates its stages in the progression of surgical disorders. The present study alsotries to correlate to stages of disease progression in modern medicine with examples to show its importance today. Theobjective of this study is to review all the literature related to Shatkriyakala in classical texts of Ayurveda and compile it in asingle place to gain comprehensive knowledge about its applied aspects and make readers mind-research oriented to think ofmanagement of disease in that stage to prevent complication. The study can be used for easy referencing for conducting furtherresearch. As this review includes a step-by-step explanation and correlation of the pathogenesis of surgical diseases, there willbe an opportunity for practitioners to provide some evidence-based medicine to incept the disease in that stage to preventdisease progression and further complications.
在阿育吠陀中,“shatkriyakal”sanchaya、prakopa、prasara、sthanasanshraya、vyakti和bheda解释了疾病进展的原因或其发病机制。这六个阶段代表了医生在病情恶化之前治疗的六个机会。它是Kriya和Kala这两个词的复合表达。Kriya表示用于治疗Dosha中断的治疗方法(药物、饮食和日常生活)的选择,Kala表示疾病进展的阶段。古印度外科医生Sushruta描述了kriyakala的概念。许多作者尝试在经典文本中编写和汇编参考文献或信息。然而,没有一篇文章不仅汇编了文献参考资料,而且解释了其适当的应用方面或将其在外科疾病进展中的阶段联系起来。本研究还试图与现代医学的疾病进展阶段相关联,并举例说明其在今天的重要性。本研究的目的是回顾阿育吠陀经典文本中与Shatkriyakala相关的所有文献,并将其汇编在一个地方,以获得有关其应用方面的全面知识,并使读者以思维研究为导向,思考该阶段的疾病管理,以防止并发症。本研究可为进一步研究提供参考。由于这篇综述包括一步一步的解释和外科疾病发病机制的相关性,从业者将有机会提供一些循证医学,在该阶段开始疾病,以预防疾病进展和进一步的并发症。
{"title":"Conceptual Study of Shatkriyakala and Its Applicability in Surgical Diseases","authors":"Dr. Akshay Kumar, Dr. Devyani Dasar, Dr. Pariksha Sharma","doi":"10.22376/ijlpr.2023.13.6.l37-l44","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l37-l44","url":null,"abstract":": In Ayurveda, \"shatkriyakal\" sanchaya, prakopa, prasara, sthanasanshraya, vyakti, and bheda explains the causes of diseaseprogression, or its etiopathogenesis. These six stages represent the six opportunities for a doctor to treat the condition beforeit becomes severe. It is a composite expression of the words Kriya and Kala. Kriya denotes the choice of therapy (medication,diet, and daily routine) used to treat the Dosha disruption, and Kala denotes the stage of a disease's progression. The idea ofKriyakala has been described by the ancient Indian surgeon Sushruta. Many authors have tried writing and compiling thereferences or information in classical texts. Still, there is no single article that not only compiles the textual references but alsoexplains its appropriate applied aspect or correlates its stages in the progression of surgical disorders. The present study alsotries to correlate to stages of disease progression in modern medicine with examples to show its importance today. Theobjective of this study is to review all the literature related to Shatkriyakala in classical texts of Ayurveda and compile it in asingle place to gain comprehensive knowledge about its applied aspects and make readers mind-research oriented to think ofmanagement of disease in that stage to prevent complication. The study can be used for easy referencing for conducting furtherresearch. As this review includes a step-by-step explanation and correlation of the pathogenesis of surgical diseases, there willbe an opportunity for practitioners to provide some evidence-based medicine to incept the disease in that stage to preventdisease progression and further complications.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"48 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135370863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohistochemical Evaluation of Cytokeratin 17 Expression in Oral Squamous Cell Carcinoma 细胞角蛋白17在口腔鳞癌组织中表达的免疫组化评价
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.l411-l420
Dr. Ankita Gyanchandani, Dr. Samarth Shukla, None Dr. RavindraKadu
Oral squamous cell carcinoma (OSCC), which makes up 80–90% of all malignant neoplasms of the mouth, is the mostcommon type of oral cancer. Immunohistochemistry plays a crucial role in diagnostic pathology by aiding in identifying andclassifying tumors IHC is utilized to study the distribution and localization of specific proteins. Identifying diagnostic markers forOSCC is essential for early diagnosis and patient-specific treatment. Cytokeratins (CK) are a family of intermediate filamentspredominantly expressed in epithelial cells. The study aimed to evaluate immunohistochemical expression cytokeratin 17 in 50cases of microscopically confirmed OSCC. The present study was observational, with retrospective and prospective sampling.The study was carried out for two years, from 2020 to 2022. The present study was designed to determine CK 17 expressionby IHC and to correlate CK 17 expression with Broders grading of OSCC and other clinical pathologic parameters.Immunostaining for CK 17 was performed. The statistical analysis was done by chi-square test. In this study, there was asignificant correlation between CK 17 expression and Broders grading, and CK 17, when correlated with other clinic pathologicparameters, showed no significant correlation. It was concluded that Cytokeratin17 expression could correlate with theBroders' Grading, thus contributing to early detection and more accurate determination of tumor aggressiveness to determineappropriate therapy.
口腔鳞状细胞癌(OSCC)占口腔所有恶性肿瘤的80-90%,是最常见的口腔癌类型。免疫组织化学在诊断病理中起着至关重要的作用,它有助于肿瘤的识别和分类。免疫组化用于研究特定蛋白的分布和定位。鉴别oscc的诊断标记对于早期诊断和患者特异性治疗至关重要。细胞角蛋白(CK)是一个主要在上皮细胞中表达的中间丝状蛋白家族。本研究旨在评价50例镜检证实的OSCC中细胞角蛋白17的免疫组化表达。本研究为观察性研究,采用回顾性和前瞻性抽样。这项研究进行了两年,从2020年到2022年。本研究旨在通过免疫组化检测CK 17的表达,并将CK 17的表达与OSCC的Broders分级和其他临床病理参数联系起来。对ck17进行免疫染色。统计学分析采用卡方检验。在本研究中,CK 17的表达与Broders分级有显著相关性,而CK 17与其他临床病理参数的相关性不显著。结果表明,细胞角化蛋白17的表达可能与broders分级相关,从而有助于早期发现和更准确地确定肿瘤的侵袭性,从而确定适当的治疗方法。
{"title":"Immunohistochemical Evaluation of Cytokeratin 17 Expression in Oral Squamous Cell Carcinoma","authors":"Dr. Ankita Gyanchandani, Dr. Samarth Shukla, None Dr. RavindraKadu","doi":"10.22376/ijlpr.2023.13.6.l411-l420","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.l411-l420","url":null,"abstract":"Oral squamous cell carcinoma (OSCC), which makes up 80–90% of all malignant neoplasms of the mouth, is the mostcommon type of oral cancer. Immunohistochemistry plays a crucial role in diagnostic pathology by aiding in identifying andclassifying tumors IHC is utilized to study the distribution and localization of specific proteins. Identifying diagnostic markers forOSCC is essential for early diagnosis and patient-specific treatment. Cytokeratins (CK) are a family of intermediate filamentspredominantly expressed in epithelial cells. The study aimed to evaluate immunohistochemical expression cytokeratin 17 in 50cases of microscopically confirmed OSCC. The present study was observational, with retrospective and prospective sampling.The study was carried out for two years, from 2020 to 2022. The present study was designed to determine CK 17 expressionby IHC and to correlate CK 17 expression with Broders grading of OSCC and other clinical pathologic parameters.Immunostaining for CK 17 was performed. The statistical analysis was done by chi-square test. In this study, there was asignificant correlation between CK 17 expression and Broders grading, and CK 17, when correlated with other clinic pathologicparameters, showed no significant correlation. It was concluded that Cytokeratin17 expression could correlate with theBroders' Grading, thus contributing to early detection and more accurate determination of tumor aggressiveness to determineappropriate therapy.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"234 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135372200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Co-Crystallization: Strategies for Co-Crystal Design 药物共晶:共晶设计策略
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.p87-p105
Preeti Devi, Vikas Budhwar, Saloni Kakkar, Ashwani Kumar
Pharmaceutical co-crystal belongs to a subtype of crystal in which one component is an active pharmaceutical ingredient (API) and the other is coformer (generally regarded as safe GRAS). In the crystal lattice, the two components are hydrogen-bonded in a fixed stoichiometric ratio. Co-crystallization is a cheap and simple alternative to the presently available techniques of solubility enhancement and has gained much interest from the formulators during the recent few years. Because co-crystals can enhance the physiochemical properties of pharmaceuticals without affecting their therapeutic effect, the area of pharmaceutical co-crystals has reached a tipping point. Besides increasing solubility, some more applications of co-crystals have also been identified to enhance physicochemical properties like permeability, bioavailability, stability, tablet ability, etc. Co-crystals have been extensively studied in the literature, and there is a tremendous amount of literature on co-crystals. However, an exhaustive review of coformer selection and co-crystal regulation must be included. An effort has been made in the review to fill this void. The current study focuses on how co-crystallization can enhance the pharmaceutical characteristics of different drugs, besides giving an overview of the historical background and landmarks in discovering co-crystals. In this review paper, we have discussed the rational design of co-crystals and the selection of conformers for the synthesis of multi-component co-crystals, methods like H-bonding, PKa value, Synthonic engineering, Cambridge structural database, Hansen solubility parameter (HSP), etc as well as the IPR related details all across the world. There is an attempt to include reported works on co-crystals, which helps understand the concept. This review paper discusses pharmaceutical regulatory bodies in the US and Europe released guidelines that are highly useful for pharmaceutical product registration in these regions. Here, we also examine various commercially available pharmaceutical drug products. It also briefly predicts the future perspective of co-crystallization.
药用共晶属于一种成分为活性药物成分(API),另一成分为共成体(通常被认为是安全的GRAS)的晶体亚型。在晶格中,这两种组分以固定的化学计量比成氢键。共结晶是一种廉价、简单的提高溶解度的方法,近年来引起了配方师们的极大兴趣。由于共晶可以增强药物的理化性质而不影响其治疗效果,因此药物共晶领域已经达到了一个临界点。除了增加溶解度外,还发现了一些更多的共晶应用,如提高渗透性、生物利用度、稳定性、片剂能力等物理化学性质。文献对共晶进行了广泛的研究,关于共晶的文献也非常多。然而,必须对共晶选择和共晶调节进行详尽的审查。在审查中已作出努力来填补这一空白。本研究除了概述共晶发现的历史背景和里程碑外,重点关注共晶如何增强不同药物的药物特性。本文综述了国内外合成多组分共晶的合理设计和构象选择、氢键、PKa值、Synthonic工程、Cambridge结构数据库、Hansen溶解度参数(HSP)等方法以及知识产权的相关细节。有一个尝试包括报道的共晶体的工作,这有助于理解这个概念。这篇综述文章讨论了美国和欧洲的药品监管机构发布的指导方针,这些指导方针对这些地区的药品注册非常有用。在这里,我们也检查各种市售药品。并简要预测了共结晶的发展前景。
{"title":"Pharmaceutical Co-Crystallization: Strategies for Co-Crystal Design","authors":"Preeti Devi, Vikas Budhwar, Saloni Kakkar, Ashwani Kumar","doi":"10.22376/ijlpr.2023.13.6.p87-p105","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.p87-p105","url":null,"abstract":"Pharmaceutical co-crystal belongs to a subtype of crystal in which one component is an active pharmaceutical ingredient (API) and the other is coformer (generally regarded as safe GRAS). In the crystal lattice, the two components are hydrogen-bonded in a fixed stoichiometric ratio. Co-crystallization is a cheap and simple alternative to the presently available techniques of solubility enhancement and has gained much interest from the formulators during the recent few years. Because co-crystals can enhance the physiochemical properties of pharmaceuticals without affecting their therapeutic effect, the area of pharmaceutical co-crystals has reached a tipping point. Besides increasing solubility, some more applications of co-crystals have also been identified to enhance physicochemical properties like permeability, bioavailability, stability, tablet ability, etc. Co-crystals have been extensively studied in the literature, and there is a tremendous amount of literature on co-crystals. However, an exhaustive review of coformer selection and co-crystal regulation must be included. An effort has been made in the review to fill this void. The current study focuses on how co-crystallization can enhance the pharmaceutical characteristics of different drugs, besides giving an overview of the historical background and landmarks in discovering co-crystals. In this review paper, we have discussed the rational design of co-crystals and the selection of conformers for the synthesis of multi-component co-crystals, methods like H-bonding, PKa value, Synthonic engineering, Cambridge structural database, Hansen solubility parameter (HSP), etc as well as the IPR related details all across the world. There is an attempt to include reported works on co-crystals, which helps understand the concept. This review paper discusses pharmaceutical regulatory bodies in the US and Europe released guidelines that are highly useful for pharmaceutical product registration in these regions. Here, we also examine various commercially available pharmaceutical drug products. It also briefly predicts the future perspective of co-crystallization.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135455101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation and Characterization of Chemical Compounds from Terminalia Chebula for Anti-Diabetic Evaluation Through In-Silico Approach 用芯片方法对苦参化合物的分离和表征进行抗糖尿病评价
Pub Date : 2023-11-01 DOI: 10.22376/ijlpr.2023.13.6.p318-p331
None Shikha, Rahul Thapa, Girish Chandra Arya, Saahil Arora
Diabetes is a chronic metabolic disorder affecting millions of people and needs to be addressed. Alternativestrategies are required for better diabetes management, as evidenced by the high costs of modern medicines. The field of herbalmedicine research has been gaining significant importance in the last few decades, and the demand to use natural products in thetreatment of diabetes is increasing across the globe. Traditional plant medicines are used worldwide for a range of diabeticcomplications. Terminalia chebula is one of the widely used traditional medicine by diabetic patients. In this present work,Terminalia chebula fruits were used for the potential of anti-diabetic activity. The phytochemical investigation revealed that itsfruit contains high amounts of tannins, alkaloids, flavonoids, terpenoids, and glycosides. The percolation method was followed byusing T. chebula fruit for the extraction, further fractionating with different solvents, n-Hexane, Ethyl acetate, n- Butanol, andwater. When ethyl acetate extract of T. chebula was tested, it was found to have significant effects on blood glucose levels. Itsuggests that it can be used as an antidiabetic agent. Gallic acid and quercetin were compounds identified by NMR, MS, andUPLC analysis. Molecular docking studies of designed compounds were carried out through Auto Dock Vina [1.1.2] toinvestigate the interaction with PPAR-γ associated with diabetes, and pkCSM software was used for ADMET analysis. Thus, theresult of the study proved that the ethyl acetate extract of T. chebula had good potential as an antidiabetic, and this plant can beused to discover natural bioactive compounds that may serve for the advances of novel pharmaceutical development. Moreover,the compounds found in the extract could be used to develop new pharmaceuticals for diabetes treatment.
糖尿病是一种影响数百万人的慢性代谢紊乱,需要得到解决。正如现代药物的高成本所证明的那样,需要采取替代策略来更好地管理糖尿病。在过去的几十年里,草药研究领域已经获得了显著的重要性,在全球范围内,使用天然产品治疗糖尿病的需求正在增加。传统植物药物在世界范围内用于治疗一系列糖尿病并发症。白芷是糖尿病患者广泛使用的中药之一。在本研究中,研究了桔梗果的抗糖尿病活性。植物化学研究表明,其果实含有大量的单宁、生物碱、黄酮类、萜类和苷类。采用渗透提取法,用正己烷、乙酸乙酯、正丁醇、水等不同溶剂进行萃取。当检测到桔梗的乙酸乙酯提取物时,发现它对血糖水平有显著的影响。这表明它可以作为一种抗糖尿病药。未食子酸和槲皮素经NMR、MS和uplc分析鉴定。通过Auto Dock Vina[1.1.2]对设计的化合物进行分子对接研究,以研究与糖尿病相关的PPAR-γ的相互作用,并使用pkCSM软件进行ADMET分析。因此,研究结果表明,chebula乙酸乙酯提取物具有良好的抗糖尿病潜力,可以利用该植物发现天然生物活性化合物,为新型药物开发提供基础。此外,提取物中发现的化合物可用于开发治疗糖尿病的新药。
{"title":"Isolation and Characterization of Chemical Compounds from Terminalia Chebula for Anti-Diabetic Evaluation Through In-Silico Approach","authors":"None Shikha, Rahul Thapa, Girish Chandra Arya, Saahil Arora","doi":"10.22376/ijlpr.2023.13.6.p318-p331","DOIUrl":"https://doi.org/10.22376/ijlpr.2023.13.6.p318-p331","url":null,"abstract":"Diabetes is a chronic metabolic disorder affecting millions of people and needs to be addressed. Alternativestrategies are required for better diabetes management, as evidenced by the high costs of modern medicines. The field of herbalmedicine research has been gaining significant importance in the last few decades, and the demand to use natural products in thetreatment of diabetes is increasing across the globe. Traditional plant medicines are used worldwide for a range of diabeticcomplications. Terminalia chebula is one of the widely used traditional medicine by diabetic patients. In this present work,Terminalia chebula fruits were used for the potential of anti-diabetic activity. The phytochemical investigation revealed that itsfruit contains high amounts of tannins, alkaloids, flavonoids, terpenoids, and glycosides. The percolation method was followed byusing T. chebula fruit for the extraction, further fractionating with different solvents, n-Hexane, Ethyl acetate, n- Butanol, andwater. When ethyl acetate extract of T. chebula was tested, it was found to have significant effects on blood glucose levels. Itsuggests that it can be used as an antidiabetic agent. Gallic acid and quercetin were compounds identified by NMR, MS, andUPLC analysis. Molecular docking studies of designed compounds were carried out through Auto Dock Vina [1.1.2] toinvestigate the interaction with PPAR-γ associated with diabetes, and pkCSM software was used for ADMET analysis. Thus, theresult of the study proved that the ethyl acetate extract of T. chebula had good potential as an antidiabetic, and this plant can beused to discover natural bioactive compounds that may serve for the advances of novel pharmaceutical development. Moreover,the compounds found in the extract could be used to develop new pharmaceuticals for diabetes treatment.","PeriodicalId":44665,"journal":{"name":"International Journal of Life Science and Pharma Research","volume":"54 12","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135455103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Life Science and Pharma Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1